Seizures as onset symptoms and rapid course in preschool children with subacute sclerosing panencephalitis

Shuang Liao1, Min Zhong1, Nan Zou1

  • 1Department of Neurology, Children's Hospital of Chongqing Medical University, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders (Chongqing), International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, China.

Brain and Behavior
|February 5, 2021
PubMed

Insights

Subacute sclerosing panencephalitis (SSPE) in preschool children presents with seizures and gait issues, rapid neurological decline, and poor outcomes. Early diagnosis is crucial for this rare condition.

Area of Science:

  • Pediatric Neurology
  • Neurodegenerative Diseases
  • Viral Encephalitis

Background:

  • Subacute sclerosing panencephalitis (SSPE) presents differently in children versus adults, often leading to early misdiagnosis.
  • Limited data exists on SSPE specifically in preschool-aged children.
  • Understanding preschool SSPE is vital for accurate diagnosis and management.

Purpose of the Study:

  • To summarize clinical data and disease progression of SSPE in preschool children.
  • To expand the known clinical phenotypes of SSPE in this age group.
  • To evaluate the outcomes and follow-up of preschool SSPE cases.

Main Methods:

  • Retrospective review and analysis of medical charts from preschool patients diagnosed with SSPE.
  • Evaluation and follow-up of clinical outcomes for enrolled cases.
  • Case series analysis of three preschool children with SSPE.

Main Results:

  • Three preschool children diagnosed with SSPE were included, with onset ages between 4 years 2 months and 5 years 2 months.
  • All patients exhibited drop attacks or jerks as initial symptoms; one also had gait disturbance.
  • Electroencephalography (EEG) showed atypical periodic complexes, and MRI revealed white matter demyelination in two cases. Neurological deterioration was rapid, with two deaths and one case progressing to vegetative state within months.

Conclusions:

  • SSPE in young children often manifests with seizures and gait instability.
  • Characteristic EEG findings include atypical periodic complexes.
  • Rapid neurological decline is a hallmark, underscoring the need for timely diagnosis and intervention.
Abstract

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
936
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
846
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
611